Marja-liisa Lindsberg-Karjalainen

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas.

A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas.

Journal: Leukemia

Published: November 13, 2025

Characterization of cancer-associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classic Hodgkin lymphoma.

Characterization of cancer-associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classic Hodgkin lymphoma.

Journal: HemaSphere

Published: January 16, 2025

Biomarker-adapted treatment in high-risk large B-cell lymphoma.

Biomarker-adapted treatment in high-risk large B-cell lymphoma.

Journal: HemaSphere

Published: November 29, 2024

Spatial Analysis of the Tumor Microenvironment in Diffuse Large B-cell Lymphoma Reveals Clinically Relevant Cell Interactions and Recurrent Cellular Neighborhoods.

Spatial Analysis of the Tumor Microenvironment in Diffuse Large B-cell Lymphoma Reveals Clinically Relevant Cell Interactions and Recurrent Cellular Neighborhoods.

Journal: Cancer immunology research

Published: November 16, 2024

Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas.

Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas.

Journal: Haematologica

Published: July 12, 2024

Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas.

Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas.

Journal: Med (New York, N.Y.)

Published: January 06, 2024

Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma.

Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma.

Journal: Blood cancer discovery

Published: September 13, 2023

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.

Journal: Blood cancer journal

Published: April 28, 2023

Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients.

Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients.

Journal: Blood advances

Published: September 20, 2021

Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment.

Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 30, 2021

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma.

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma.

Journal: Blood

Published: June 07, 2021

The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma.

The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma.

Journal: EJHaem

Published: September 04, 2020

Showing 1-12 of 49

Last Updated: 09/26/2026